PERLINI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 9.516
AS - Asia 6.780
EU - Europa 5.426
SA - Sud America 853
AF - Africa 259
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.867
Nazione #
US - Stati Uniti d'America 9.292
CN - Cina 2.920
SG - Singapore 1.628
IE - Irlanda 1.175
HK - Hong Kong 769
RU - Federazione Russa 686
IT - Italia 637
VN - Vietnam 634
BR - Brasile 632
DE - Germania 608
UA - Ucraina 586
FI - Finlandia 540
FR - Francia 336
GB - Regno Unito 275
SE - Svezia 240
IN - India 174
ZA - Sudafrica 163
BD - Bangladesh 122
CA - Canada 120
AR - Argentina 80
JP - Giappone 73
IQ - Iraq 69
MX - Messico 66
TR - Turchia 65
BE - Belgio 56
PL - Polonia 53
NL - Olanda 44
ES - Italia 41
ID - Indonesia 40
EC - Ecuador 35
PK - Pakistan 35
CO - Colombia 29
UZ - Uzbekistan 28
AT - Austria 27
CZ - Repubblica Ceca 27
IR - Iran 27
VE - Venezuela 23
CL - Cile 22
LT - Lituania 21
PH - Filippine 21
AU - Australia 19
JO - Giordania 19
MA - Marocco 19
MY - Malesia 18
SA - Arabia Saudita 18
PY - Paraguay 16
EG - Egitto 14
AL - Albania 13
DZ - Algeria 13
LB - Libano 12
AZ - Azerbaigian 11
KZ - Kazakistan 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
IL - Israele 9
JM - Giamaica 9
KE - Kenya 8
SN - Senegal 7
UY - Uruguay 7
AM - Armenia 6
BH - Bahrain 6
GR - Grecia 6
KG - Kirghizistan 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
CH - Svizzera 5
ET - Etiopia 5
GT - Guatemala 5
NO - Norvegia 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
RS - Serbia 5
TH - Thailandia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
GE - Georgia 4
NI - Nicaragua 4
AO - Angola 3
CG - Congo 3
CR - Costa Rica 3
CY - Cipro 3
DK - Danimarca 3
EU - Europa 3
KW - Kuwait 3
LK - Sri Lanka 3
MU - Mauritius 3
PA - Panama 3
QA - Qatar 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
Totale 22.823
Città #
Chandler 1.233
Dublin 1.173
San Jose 1.046
Singapore 861
Ashburn 797
Dallas 750
Hong Kong 742
Jacksonville 733
Beijing 559
Nanjing 559
Boardman 391
Los Angeles 246
Ann Arbor 243
Lauterbourg 231
Princeton 220
Nanchang 218
Lawrence 210
Wilmington 210
Ho Chi Minh City 209
Helsinki 183
New York 168
Shenyang 164
Hebei 160
Munich 153
Milan 150
Medford 148
Hanoi 145
Council Bluffs 141
Changsha 138
Moscow 137
Johannesburg 136
Jiaxing 111
Redondo Beach 111
Buffalo 105
Pavia 102
Shanghai 96
Tianjin 84
Hangzhou 76
São Paulo 68
Tokyo 67
Turku 66
Orem 63
Santa Clara 61
Brussels 56
Woodbridge 51
Toronto 47
Warsaw 42
Norwalk 41
Seattle 41
Montreal 40
Brooklyn 38
Da Nang 38
Frankfurt am Main 38
Chicago 37
Chennai 36
Falls Church 36
London 36
Houston 35
Falkenstein 34
Saint Petersburg 34
Haiphong 32
Atlanta 31
Nuremberg 31
Verona 31
Boston 30
Guangzhou 30
The Dalles 30
Fairfield 29
Denver 27
Mexico City 27
Baghdad 24
Stockholm 24
Amsterdam 23
Brno 23
Phoenix 23
San Francisco 23
Tashkent 23
Rio de Janeiro 22
Zhengzhou 22
Manchester 20
Piscataway 19
Rome 19
Des Moines 18
Columbus 17
Amman 16
Curitiba 16
Jinan 16
Poplar 16
Pune 16
Taizhou 16
Charlotte 15
Mumbai 15
Vienna 15
Ankara 14
Biên Hòa 14
Guayaquil 14
Washington 14
Istanbul 13
Kunming 13
Dhaka 12
Totale 14.977
Nome #
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance 176
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 160
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 158
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 153
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 152
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 150
La simulazione su manichino migliora l’abilità degli studenti di Medicina nell’auscultazione cardiaca? L’esperienza di Pavia 149
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers. 149
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 149
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. 148
Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation. 142
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 141
Remote matrix metalloproteinases activation as systemic consequence pf liver injury: the role of lung. 139
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 138
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 138
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 137
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 136
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 136
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 134
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 133
Treatment of chronic heart failure: an expert system advisor for general practitioners. 132
Effect of chronic sympatectomy in a model of rat cardiac hypertrophy: role of the extracellular matrix. 131
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 131
Adenosine 128
Adherence of the guidelines in an Italian ED in case of minor head trauma (MHI) in real life 127
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 127
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 126
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 125
Right ventricular function in AL amyloidosis: characteristics and prognostic implication 124
A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis 124
Experience from controlled trials of physical-training in chronic heart-failure-protocol and patient factors in effectiveness in the improvement in exercise tolerance 123
Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium 123
Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling? 123
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 122
Lung-ultrasound objective structured assessment of technical skills (LUS-OSAUS): utility in the assessment of lung-ultrasound trained medical undergraduates 120
Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. 120
Comparative analysis of a 4-lead portable smartphone based electrocardiograph versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 119
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 118
Alterations in Early Filling Dynamics Predict the Progression of Compensated Pressure Overload Hypertrophy to Heart Failure Better than Abnormalities in Midwall Systolic Shortening 118
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 118
Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? 117
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 116
Determinants of respiratory sinus arrhythmia in the vagotomized rabbit. 115
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. 115
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System 115
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 115
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 113
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 113
Autonomic and ventilatory components of heart rate and blood pressure variability in freely behaving rats. 111
Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19 111
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 110
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 110
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 109
Machine-Learning-Based COVID-19 and Dyspnoea Prediction Systems for the Emergency Department 108
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 108
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 108
Analisi preliminare di un sistema esperto per la diagnosi cardiologica incruenta. 107
Simulation-guided cardiac auscultation improves medical students' clinical skills: the Pavia pilot experience 107
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 107
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 107
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 107
Assessment of regional myocardial performance with end-systolic pressure lenght and thickness relationships. 106
Lung ultrasound presentation of COVID-19 patients: phenotypes and correlations 105
Effects of the chronic digoxin administration on extracellular matrix turnover in a model of cardiac hypertrophy in Guinea pigs. 105
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44 105
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 105
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 105
Lack of contribution of autonomic influences to vascular nitric oxide release? Studies in the unanesthetized rat. 104
Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats 104
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis 104
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 104
Deep learning and lung ultrasound for Covid-19 pneumonia detection and severity classification 104
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure 103
Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis 103
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 103
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 102
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. 102
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis 102
An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis 102
Matrix metalloproteinases: analysis of the activity in Guinea pig cardiac hypertrophy. 101
Semplice algoritmo per la valutazione del rilasciamento isovolumetrico del ventricolo sinistro. 101
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 101
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 101
QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine 101
Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects 100
Ultrasonic integrated backscatter as a useful and tool to noninvasively study myocardial function and fibrosis in hypertensive heart disease 99
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 99
Evaluation of matrix metalloproteases activity in Guinea pig cardiac hypertrophy. 99
Antiadrenergic effects of adenosine in pressure overload hypertrophy. 97
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 96
Enhanced vascular reactivity in the sympathectomized rat: studies in vivo and in small isolated resistance arteries 95
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 95
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 94
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy 94
Reproducibility of ultrasound assessment of common carotic and femoral artery compliance and distensibility in the anesthetized rat. 94
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy 94
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 94
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 94
Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 93
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 93
Totale 11.629
Categoria #
all - tutte 98.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/20221.017 19 15 38 16 39 36 31 71 61 31 153 507
2022/20233.398 379 240 51 296 350 350 3 184 1.392 17 90 46
2023/20241.268 164 201 47 86 116 292 38 75 10 60 83 96
2024/20253.836 129 278 74 162 93 220 219 233 928 142 437 921
2025/20268.926 643 621 924 975 1.066 422 1.705 397 816 723 409 225
Totale 23.173